Life Sciences Opportunities in Ireland

An Expert's View about Pharmaceuticals in Ireland

Posted on: 4 Oct 2010

Under the NDP 2007-2013, €20bn will be provided for science, technology and innovation (STI) in order to transform the quality of research and improve economic and social development in Ireland.

Sector briefing Life Sciences Opportunities in Ireland Why Ireland? This sector includes the key industries of Biotechnology, Pharmaceuticals and Chemicals. Under the National Development Plan 2007- 2013 (NDP) www.ndp.ie ?20bn will be provided for science, technology and innovation (STI) in order to transform the quality of research and improve economic and social development in Ireland. Find general information on Irish market conditions on UKTI?s website. The Doing Business Guide for Ireland gives an overview of Ireland?s economy, business culture, potential The Science Foundation Ireland (SFI) opportunities and an introduction to other www.sfi.ie provides a vital role within the life relevant issues. sciences sector especially in the area of biotechnology. SFI helps Ireland recruit and retain research groups capable of developing high-impact, internationally significant discoveries in these areas. SFI makes grants based upon the merit review of distinguished scientists. UK Trade & Investment Sector briefing: Life Sciences opportunities in Ireland diagnostic and biopharmaceutical companies. Opportunities Ireland has succeeded in attracting a large pharmaceutical manufacturing sector, Biotechnology employing 12,000 people in 80 companies. (By comparison, the UK employs 73,000 A new phase of biotechnological development people in pharmaceutical manufacturing). Nine is becoming evident, that is, a transition to of the top ten companies in the world have genomics. Ireland, with the appropriate manufacturing operations in Ireland. Of the investments, is well placed to enter this phase present global pharma-products, an estimated and eventually to take a leading position. 16 per cent are of biotechnological origin or are Biotechnology and genomics are particularly related to biotechnology. suitable to Ireland and Ireland is particularly suitable to these technological and The Primary Manufacturing Companies environmentally-friendly industries for the following reasons; the major components of These companies are involved in chemical the health and life sciences industry manufacturing producing active pharmaceutical (pharmaceuticals, chemicals, etc.) are well ingredients supplying the secondary established in Ireland and account for manufacturing sector. This sector in Ireland significant employment, exports and revenue. consists of many of the top global players All these sectors are in transition and the new including companies such as Merck Sharp and developments are strongly influenced by Dohme in Clonmel, Schering Plough in biotechnology. Wicklow, Yamanouchi in West Dublin, SmithKline Beecham in Cork, Roche in the Mid The biotechnology industry is highly research West, Bristol Meyers Squibb in North Dublin, oriented. Irish institutes and universities have and Pharmacia Upjohn in Cork. The sector has well-established biotechnology programmes. its greatest concentration in the Cork area However, the research and education where over the past 30 years there has been a infrastructure needs to be significantly steady stream of international companies improved if Ireland is to keep pace and create either starting up new manufacturing a thriving biotechnology sector. subsidiaries or expanding existing ones. BioResea The Secondary Pharmaceutical sector is rch Ireland (BRI) www.biotechnologyireland.com engaged in formulating, production and has established packaging a final product (i.e. Tablet, the infrastructure for managing the Parenterals, and Cream etc.). The commercialisation of research output from Irish un manufacturing technologies utilised in this area iversities. These mechanisms can be enhanced broadly involve a wide range of automated and improved. equipment involved in discrete activities such as blending & mixing, forming and filling, and IBEC has formed the Irish Bio-Industries Association (IBIA) www high speed packing and distribution. .ibec.ie in order to Companies like Organon in Swords, part of improve the awareness of biotechnology and to meet the needs of the I AKZO, and Wyeth in Newbridge, part of rish biotechnology American Home Products, have seen industry. substantial growth in recent years. Wyeth in The Irish Pharmaceutical and Newbridge employs over 1500 people engaged Biopharmaceutical Sectors in manufacturing tablets while Organon employs over 500 people in the manufacturer of solid dosage and injectables. Other The Irish Government has identified the companies in this sector include Leo development of this industrial sector as one of Laboratories (fully integrated site in Dublin the country's best options for the future. The engaged in Primary & Secondary Irish pharmaceutical sector currently generates manufacturing), Schering Plough in Bray 45% of Ireland's exports. Over ?4.3bn has Animal Health Products, and Elan in Athlone- been invested by the pharmaceutical sector in Ireland over the last six years. The challenge Drug Delivery Technologies (consisting of R&D, is to increase the amount of research and Manufacturing and Sales & Marketing). development activities undertaken by multinationals in Ireland and at the same time increase significantly the number of fully integrated indigenous pharmaceutical, UK Trade & Investment Sector briefing: Life Sciences opportunities in Ireland The Diagnostic manufacturing area in Ireland, although small in comparison to the Pharmaceutical sectors does have a number of successful indigenous companies such as Trinity Biotech plc and Biotrin. Trinity Biotech develops, manufactures and markets diagnostic products for the point-of-care, and clinical laboratory segments of the diagnostic market whilst Biotrin specialises in providing a range of novel and proprietary tests for the Clinician and Research Scientist. However indigenous there are also a good number of multinational subsidiaries in this sector including Abbott Diagnostics in Sligo and Olympus Diagnostics in Clare who have very sizeable operations here in Ireland. Biopharmaceuticals impact on the 21st Century will be as significant as the Microchip effect on society and industry in the second half of the 20th century. Basically Biopharmaceuticals is concerned with the alteration of molecules, genes and cells - the basic building blocks of life - to develop useful products, processes or services such as new medicines and therapies. In Ireland this sector received a major boost with the construction of the Wyeth Biopharma Campus in Clondalkin, Dublin, at a cost of ?1.2billion ? the largest single site investment in the Pharmaceutical sector world-wide. Along with Schering Plough, Brinny and Genzyme in Waterford, Ireland is steadily growing its Biopharmaceutical sector. Allied to this we have a group of indigenous companies such as Ntera (Nanotechnology), Archport (contract production and R&D services), ThromboGenics (innovative pharmaceuticals for the prevention and treatment of cardiovascular diseases). Chemicals The chemical industry is important, comprising about 45 companies and employing approximately 4,000 people. Pharma/chem is the second largest export sector in Ireland after engineering/ electronics and represents about 20 per cent of manufactured goods exported. The effects of biotechnology on the chemical industry can be seen in many ways. For example, chemical companies are using biotechnology to develop novel manufacturing processes. They are developing clean biodegradable biological compounds as substitutes for ?dirty? chemicals. Some chemical companies are gradually moving out of the chemical industry altogether and into biotechnology. UK Trade & Investment Sector briefing: Life Sciences opportunities in Ireland Major events and activities UKTI contacts Medtec Ireland Simon McKeever Galway Director Trade & Investment 22 ? 23 September 2010 British Embassy Dublin Conference and exhibition with over 100 Tel: 00 353 1 205 3769 exhibitors, across Medical device design and Email: simon.mckeever@fco.gov.uk manufacture. Web: www.britishembassy.ie www.canontradeshows.com/expo/medtire09 Andrew Evans Trade Advisor Find full details of all events in this British Embassy Dublin country and sector on the UKTI website. Tel: 00 353 1 205 3753 New export events are added daily to the site Email: andrew.evans3@fco.gov.uk and you can register to be alerted to them on a Web: www.britishembassy.ie daily, weekly or monthly basis. UKTI?s Tradeshow Access Programme (TAP) provides grant support for eligible Small & Medium Sized Enterprises (SME's) to attend trade shows overseas. Find out more about UKTI support for attendance at overseas events. UK Trade & Investment Sector briefing: Life Sciences opportunities in Ireland Next steps - How UKTI can help British companies wishing to develop their This work is available via our Overseas Market business in the Irish market are advised to Introduction Service (OMIS) a chargeable undertake as much market research and service which assists British-based companies planning as possible in the UK. UKTI?s team in wishing to enter or expand their business in Ireland, with its wide local knowledge and overseas markets. experience, can provide a range of services to British-based companies wishing to grow their To find out more about commissioning this business in global markets. work, or accessing other UKTI services and specialist advice, please visit the UKTI website This can include: to find contact details for your local UKTI ? Provision of market information office. ? Validated lists of agents/distributors ? Key market players or potential customers in the Irish market ? Establishment of interest of such contacts in working with you ? Arranging appointments ? Organise seminars or other events for you to meet contacts and promote your company in the Irish market Whereas every effort has been made to ensure that the information given in this document is accurate, neither UK Trade & Investment nor its parent Departments (the Department for Business, Innovation & Skills, and the Foreign & Commonwealth Office), accept liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, firm, company or other organisation mentioned. Published 2010 by UK Trade & Investment. Crown Copyright © UK Trade & Investment Sector briefing: Life Sciences opportunities in Ireland
Posted: 04 October 2010

See more from Pharmaceuticals in Ireland

Expert Views    
Life Sciences Opportunities in Ireland   By UK Trade & Investment
Pharmaceutical Opportunities   By UK Trade & Investment
Presenting the contributor